Answers are grounded in this paper and cite their sources.
This multicenter case-control study assessed (2019-2023) the association of oral and anogenital human papillomavirus (HPV) genotypes with head and neck cancers in Brazil. Eligible cases were adults (≥ 18 years) with newly diagnosed, histologically confirmed squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx. Controls (cancer-free individuals) were matched a posteriori by region, sex, and age. Oral, genital, and anal samples were collected and processed at a central laboratory for HPV genotyping. Associations were estimated using conditional regression. Analyses included 314 participants (157 cases, 157 controls), mostly males (79%) aged 50-65 years (51%). Oral HPV prevalence was similar between cases and controls (14% vs. 12%), predominantly involving high-risk genotypes (35 out of 40); HPV-16/18 was more prevalent among cases (7.3% vs. 1.9%; p = 0.024), with most HPV-16/18-positive cancers located in the oropharynx (10 out of 11). Genital HPV prevalence was 39% with no case-control differences, while anal HPV prevalence was 17%. Cases were more frequently positive for any high-risk anal HPV type than controls (16% vs. 9%; p = 0.049). Minimal genotype concordance was observed between oral and anogenital sites. Current smokers had ten-fold higher odds of being cases (adjustedOR 10.0; 95% CI 2.92-34.6). Oral HPV-16/18 infection was independently associated with head and neck cancer (adjustedOR 6.30; 95% CI 1.52-26.1). Multisite HPV genotyping revealed site-specific colonization patterns, with genital infections being most prevalent among both men and women. After multivariable adjustment, only oral HPV-16/18 infection was strongly associated with head and neck cancer, especially oropharyngeal carcinoma.
No takes yet. Share an insight, caveat, or question.
Pilz et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: